Published in World J Stem Cells on November 26, 2014
Therapeutic Potential of Differentiated Mesenchymal Stem Cells for Treatment of Osteoarthritis. Int J Mol Sci (2015) 0.84
Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies. Stem Cell Res Ther (2016) 0.80
Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. Mol Ther (2016) 0.79
Non-operative management of osteoarthritis of the knee joint. J Clin Orthop Trauma (2016) 0.77
Electroacupuncture inhibits chronification of the acute pain of knee osteoarthritis: study protocol for a randomized controlled trial. Trials (2015) 0.77
A new treatment for knee osteoarthritis: Clinical evidence for the efficacy of Arthrokinex™ autologous conditioned serum. J Orthop (2016) 0.75
Photobiomodulation therapy in the modulation of inflammatory mediators and bradykinin receptors in an experimental model of acute osteoarthritis. Lasers Med Sci (2016) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells (2007) 8.64
Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol (2004) 5.43
Clinical practice. Osteoarthritis of the knee. N Engl J Med (2006) 4.69
Osteoarthritis: an update with relevance for clinical practice. Lancet (2011) 4.18
Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther (2007) 3.97
The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int (2010) 3.83
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol (2010) 3.14
Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat Biotechnol (2008) 2.84
Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol (2008) 2.79
Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol (2011) 2.74
The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol (2010) 2.21
Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum (2002) 2.20
Unlike bone, cartilage regeneration remains elusive. Science (2012) 1.90
Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther (2007) 1.85
Genetic epidemiology of hip and knee osteoarthritis. Nat Rev Rheumatol (2010) 1.67
Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol (2008) 1.67
Technology Insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol (2006) 1.66
The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol (2010) 1.54
Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone (2006) 1.50
Tissue engineering for articular cartilage repair--the state of the art. Eur Cell Mater (2013) 1.48
Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis (2011) 1.39
Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet (2012) 1.38
Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev (2011) 1.30
Mesenchymal stem cells for cartilage repair in osteoarthritis. Stem Cell Res Ther (2012) 1.26
Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Ther (2009) 1.22
Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy. Histol Histopathol (2009) 1.21
Etiology of osteoarthritis: genetics and synovial joint development. Nat Rev Rheumatol (2012) 1.16
Chondrogenesis in a hyaluronic acid scaffold: comparison between chondrocytes and MSC from bone marrow and adipose tissue. Knee Surg Sports Traumatol Arthrosc (2009) 1.14
Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng (2006) 1.10
Current perspectives in stem cell research for knee cartilage repair. Stem Cells Cloning (2014) 1.09
Stem cell-based therapies for osteoarthritis: challenges and opportunities. Curr Opin Rheumatol (2013) 1.04
Stem cells and cartilage development: complexities of a simple tissue. Stem Cells (2010) 1.02
Comparing two low-energy diets for the treatment of knee osteoarthritis symptoms in obese patients: a pragmatic randomized clinical trial. Osteoarthritis Cartilage (2010) 1.01
Mesenchymal stem cells as a potent cell source for articular cartilage regeneration. World J Stem Cells (2014) 1.01
The genetic epidemiology of osteoarthritis. Curr Opin Rheumatol (2010) 1.00
The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele. Cell Death Differ (2014) 0.99
Deficient DNA damage response and cell cycle checkpoints lead to accumulation of point mutations in human embryonic stem cells. Stem Cells (2012) 0.98
IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort. Osteoarthritis Cartilage (2013) 0.98
The role of DNA repair in the pluripotency and differentiation of human stem cells. Mutat Res (2012) 0.96
Stem cell therapy for cartilage regeneration in osteoarthritis. Expert Opin Biol Ther (2009) 0.96
New trends for knee cartilage regeneration: from cell-free scaffolds to mesenchymal stem cells. Curr Rev Musculoskelet Med (2012) 0.96
Current nutraceuticals in the management of osteoarthritis: a review. Ther Adv Musculoskelet Dis (2012) 0.94
The burden of musculoskeletal conditions. PLoS One (2014) 0.93
Risk factors for incident osteoarthritis of the hip and knee. Curr Rev Musculoskelet Med (2011) 0.92
Current concepts: the role of mesenchymal stem cells in the management of knee osteoarthritis. Sports Health (2015) 0.90
New perspectives for articular cartilage repair treatment through tissue engineering: A contemporary review. World J Orthop (2014) 0.87
Mesenchymal stem cells in regenerative medicine for musculoskeletal diseases: bench, bedside, and industry. Cell Transplant (2014) 0.87
Osteoarthritis year 2010 in review: genetics. Osteoarthritis Cartilage (2011) 0.85
Stem cells and other innovative intra-articular therapies for osteoarthritis: what does the future hold? BMC Med (2012) 0.82
Nutraceuticals in the management of osteoarthritis : a critical review. Drugs Aging (2012) 0.81
Clinical and experimental approaches to knee cartilage lesion repair and mesenchymal stem cell chondrocyte differentiation. Biol Res (2013) 0.79
Treatment of osteoarthritis with mesenchymal stem cells. Sci China Life Sci (2014) 0.79
Osteoarthritis susceptibility genes continue trickling in. Lancet (2012) 0.77
SMAD3 is associated with the total burden of radiographic osteoarthritis: the Chingford study. PLoS One (2014) 0.77
What's your poison? Impact of individual repair capacity on the outcomes of genotoxic therapies in cancer. Part II - information content and validity of biomarkers for individual repair capacity in the assessment of outcomes of anticancer therapy. Biotechnol Biotechnol Equip (2014) 0.77